Evaluation of the Safety and Performance of an Injectable Hyaluronic Acid Filler

Midface Volume Deficit Clinical Trial

Official title:
Prospective, Interventional, Non-Randomized, Open Label Study for the Evaluation of the Safety and Performance of an Injectable Hyaluronic Acid Filler

Status Completed

Clinical Trial Summary

Evaluation of the safety and performance of the investigational device in its three concentrations for cheek and lips augmentation and correction of the nasolabial folds, assuming that the performance of the product will be demonstrated based on the responder rates observed compared to baseline.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04971876
Study type	Interventional
Source	Hallura Ltd.
Contact
Status	Completed
Phase	N/A
Start date	October 27, 2020
Completion date	September 6, 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04132518` - Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency	N/A
Completed	`NCT03532126` - A 52-week Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit
Active, not recruiting	`NCT04784299` - To Evaluate the Performance and Safety of YVOIRE Volume Plus for Improvement of Mid-face Volume	N/A
Completed	`NCT03289052` - Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency	N/A
Completed	`NCT03097783` - Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency	N/A